Get 20% lifetime commission for referring investors to digrin.com
here.
vTv Therapeutics Inc. ( VTVT) - Key Metrics
VTVT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.05 | -$0.92 | -$0.92 |
| 2026Q1 | $4.37 | $2.87 | $1.09 | $1.09 |
| 2025Q4 | $0 | -$0.85 | -$1.10 | -$1.10 |
| 2025Q3 | $0 | -$1.08 | -$0.65 | -$0.65 |
| 2025Q2 | $0 | -$0.92 | -$0.77 | -$0.77 |
VTVT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.96 |
| 2026Q1 | 0% | 3.45 |
| 2025Q4 | 0% | -11.76 |
| 2025Q3 | 0% | -5.41 |
| 2025Q2 | 0% | -4.08 |
VTVT
Price: $31.48
52 week price:
Earnings Per Share: -0.75 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 36900
Ebitda: -11.5 millionMarket Capitalization: 118.6 million